Saint John Regional Hospital is a Canadian hospital in Saint John, New Brunswick. Operated by Horizon Health Network, Saint John Regional Hospital opened in 1982, replacing the Saint John General Hospital ...

There are 524 beds in Regional Health Authority B, Zone 2.

During the past decade, Regional Health Authority B, Zone 2 conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 10 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Health Authority B, Zone 2" #1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Regional Health Authority B, Zone 2" are "Non-Small Cell Lung Cancer" (3 trials), "Breast Cancer" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Anxiety Disorder" (1 trials) and "B-Cell Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Regional Health Authority B, Zone 2" in a lesser frequency.

Most popular intervention types in "Regional Health Authority B, Zone 2" are "Drug" (17 trials), "Other" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cyclophosphamide" (3 trials), "Chlorambucil" (2 trials), "Cisplatin" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Regional Health Authority B, Zone 2" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Regional Health Authority B, Zone 2". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Regional Health Authority B, Zone 2, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Health Authority B, Zone 2, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".